Figure 3From: Transient antiretroviral therapy selecting for common HIV-1 mutations substantially accelerates the appearance of rare mutationsClinical nevirapine data. Relative fractions of K103N variants in maternal plasma viral RNA after single dose nevirapine for three individual women (NVP16, NVP19 and NVP196). We read data off a chart published in [24]. In this study, the relative abundance of K103N declined to undetectable levels by 12 months [24].Back to article page